ABO Blood Group Research Articles

Rapid parallel blood typing on centrifugal microfluidic platform by microcolumn gel immunoassay

Microcolumn gel immunoassay (MGIA) has the ability to meet the requirements of clinical diagnosis due to its reliable sensitivity and accuracy. However, traditional MGIA exhibits limitations including inadequate portability, low throughput, and extended analysis time. To address these challenges, we combined MGIA with microfluidic technology, demonstrating a centrifugal microfluidic-based microcolumn gel immunoassay (μMGIA) platform for blood typing of clinical samples. Experimental results indicate that the μMGIA platform can simultaneously detect six blood group antigens in five clinical blood samples within 2 min. Notably, it offers comprehensive detection of ABO blood group antigens and Rh blood group antigens with 100 % accuracy, outperforming the traditional slide method. The integration of microfluidic technology with MGIA circumvents the constraints of traditional methods, providing a new avenue for blood typing and immunoanalysis of clinical samples.

Examination of the relationship between ABO/Rh blood groups and dietary compliance in children with coeliac disease: A single-centre experience.

Coeliac disease (CD) is an autoimmune enteropathy that develops upon ingestion of food containing gluten. The established link between ABO blood groups and numerous infectious and non-infectious illnesses prompted this investigation into blood group distribution and its relationship with dietary compliance among children diagnosed with CD. In this retrospective study, patients with CD who were followed for ≥1 year at the paediatric gastroenterology outpatient clinic of our hospital were evaluated. History, physical examination and coeliac serology results were reviewed for each patient. Patients were divided into two groups based on self-reported compliance to a gluten-free diet: diet-adherent and non-diet-adherent. Patient and control groups were examined in terms of ABO blood groups. A total of 177 patients with CD were included in the study. A control group of 211 age- and sex-matched children without any chronic disease who had undergone blood group testing for various reasons was included for comparison. A total of 65% (n = 115) of the patients were girls, and 35% (n = 62) were boys. No significant relationship was found between CD diagnosis and ABO blood groups among patients (P = 0.559). Furthermore, the dietary compliance status of the patients was not associated with any specific blood group (P = 0.951). No notable difference was found between patients with CD with or without gluten-free diet compliance in terms of the distribution of ABO blood groups and Rhesus (Rh) factor. Therefore, it can be inferred that all blood groups and subgroups carry an equal risk for CD.

Correlation between ABO blood group and clinical characteristics of patients with lupus nephritis

Correlation between ABO blood group and clinical characteristics of patients with lupus nephritis

Survival benefit of liver transplantation utilizing marginal donor organ according to ABO blood type.

The current liver transplantation (LT) allocation policy focuses on the Model for End-Stage Liver Disease (MELD) scores, often overlooking factors like blood type and survival benefits. Understanding blood types' impact on survival benefits is crucial for optimizing the MELD 3.0 classification. This study used the United Network for Organ Sharing national registry database (2003-2020) to identify LT characteristics per ABO blood type and to determine the optimal MELD 3.0 scores for each blood type, based on survival benefits. The study included LT candidates aged 18 years or older listed for LT (total N=150,815; A:56,546, AB:5,841, B:18,500, O:69,928). Among these, 87,409 individuals (58.0%) underwent LT (A:32,156, AB:4,362, B:11,786, O:39,105). Higher transplantation rates were observed in AB and B groups, with lower median MELD 3.0 scores at transplantation (AB:21, B:24 vs. A/O:26, p<0.01) and shorter waiting times (AB:101 days, B:172 days vs. A:211 days, O:201 days, p<0.01). A preference for Donation after Cardiac Death (DCD) was seen in A and O recipients. Survival benefit analysis indicated that B blood type required higher MELD 3.0 scores for transplantation than A and O (Donation after Brain Death transplantation: ≥15 in B vs. ≥11 in A/O; DCD transplantation: ≥21 in B vs. ≥11 in A, ≥15 in O). The study suggests revising the allocation policy to consider blood type for improved post-LT survival. This calls for personalized LT policies, recommending higher MELD 3.0 thresholds, particularly for individuals with type B blood.

Prognostic value of ABO blood groups in upfront operated pancreatic ductal adenocarcinomas

PurposePancreatic ductal adenocarcinoma (PDAC) has been shown to have a lower incidence in patients with blood group O. It is currently uncertain if patients with group O have a better prognosis after pancreatectomy. This study assessed the overall survival (OS) and disease-free survival (DFS) of PDAC patients who underwent upfront pancreatoduodenectomy based on ABO blood groups.MethodsA cross-sectional study was performed including patients from two university centers. All consecutive head PDAC patients who underwent upfront pancreatoduodenectomy from 2000 to 2016 were included. OS and DFS were compared between blood groups A, B, AB, and O using Kaplan-Meier curves and log-rank tests.ResultsA total of 438 patients were included (215 women, median age 67). Pre- and intraoperative details were comparable between all subgroups. Median OS did not differ between the four blood groups (A: 23 months, 95% CI 18–28; B: 32, 95% CI 20–44; AB: 37, 95% CI 18–56 and O: 26, 95% CI 20–32, p = 0.192). Median DFS were also similar (A: 19 months, 95% CI 15–23; B: 26, 95% CI 19–33; AB: 35, 95% CI 15–55 and O: 22, 95% CI 15–29, p = 0.441). There was no OS difference between O and non-O groups (median: 26 months, 95% CI 20–33 vs. 25 months, 95% CI 20–30, p = 0.773). On multivariable analysis blood groups were not prognostic of OS. Only lymph node involvement, tumor differentiation, and adjuvant chemotherapy were independent prognostic factors.ConclusionOS and DFS were similar between all four blood groups after pancreatoduodenectomy. Independent predictors of OS were associated with tumor characteristics and adjuvant treatment.

Distribution of ABO and D antigen expression in Yogyakarta, Java Island: a pioneer large-scale study in Indonesia

ObjectiveHere, we sought to report ABO and D antigen distribution in blood donors from Yogyakarta, Java Island, Indonesia. Phenotype data (ABO/D) from donors who donated blood between January 1, 2018, and December 31, 2023, at the Yogyakarta Blood Donor Unit were extracted from the blood donor registry, and phenotype frequency was calculated subsequently.ResultsIn the 245,307 blood donors collected over six years, ABO phenotype frequency: O (frequency: 38.5%) > B (29.4%) > A (24.1%) > AB (8.0%). The D-positive phenotype was far more common (99.5%) than the D-negative phenotype (0.5%). The phenotypic pattern globally is similar to previous reports in Southeast Asia. The D antigen distribution is similar to world distribution as the most common blood group. For the first time in Indonesia, this distribution of ABO and D phenotype is reported in a large-scale study. This work is a pioneer in the coordinated optimization of transfusion guidelines at the national level.

Association between ABO blood groups and hematological myeloid neoplasms in adolescents and adults.

Prior research suggests a potential link between ABO blood types and susceptibility to various malignancies. The correlation between ABO blood types and hematological myeloid neoplasms, however, remains inadequately explored. This study investigates the association between ABO blood groups and the incidence of hematological myeloid neoplasms in adolescents and adults. In this retrospective clinical study, 1,022 adolescent and adult cases of myeloid neoplasms diagnosed at our institution were initially considered. After excluding conditions potentially linked to ABO blood types from prior studies, 792 eligible cases were analyzed. These cases were categorized based on disease subtypes and compared with a control group for blood type distribution. Our findings reveal a significantly higher prevalence of blood type A in patients with myeloid neoplasms compared to the control group, except for chronic myelocytic leukemia and myeloproliferative neoplasms. Conversely, the prevalence of blood type AB in myeloid neoplasms was notably lower than in the control group. The study suggests a potential association between ABO blood types and the risk of developing hematological myeloid neoplasms in adolescents and adults. Further research is warranted to elucidate the underlying mechanisms of this relationship.

ABO blood group, ABO mismatched transfusions and leukoreduction of transfusions in hemostatic resuscitation studies.

ABO blood group, ABO mismatched transfusions and leukoreduction of transfusions in hemostatic resuscitation studies.

Association of Diabetes Mellitus with Salivary Secretor Status of ABO Blood Group

Association of Diabetes Mellitus with Salivary Secretor Status of ABO Blood Group

Abstract A024: ABO blood type and overall survival in patients with pancreatic adenocarcinoma: A systematic review and meta-analysis

Abstract Background/Aim: Recent studies have reported that blood group antigens influence the risk of pancreatic cancer. However, studies on the influence of ABO blood groups on the outcomes of pancreatic cancer have been controversial. Therefore, we aimed to perform a systematic review and meta-analysis to evaluate the association between ABO blood groups and the overall survival in patients with pancreatic adenocarcinoma. Methods: A systematic review of the literature was conducted using the PubMed/Medline, Cochrane Library, and Embase databases in June 2024. This review included observational studies published as complete articles that assessed overall survival or mortality in patients with pancreatic cancer with O blood group compared to non-O. Review Manager 5.1 was used for statistical analysis. Hazard ratios (HRs) with 95% CI were pooled across studies. A random-effects model was used for outcomes with high heterogeneity. In cases where significant heterogeneity was observed (I2 &amp;gt; 40%), sensitivity analyses were conducted. Statistical significance was defined as a p-value &amp;lt; 0.05. Results: Of the 1,624 entries initially identified, nine retrospective studies were included in this meta-analysis, comprising 4,965 individuals. Individuals with O blood type had no statistically significant difference in overall survival compared to the non-O group (HR 1.22; 95% CI 0.97 to 1.53; p = 0.09; I2 = 70%). However, sensitivity analysis revealed one study as the main source of heterogeneity, and its exclusion significantly modified the results favoring the O blood group (HR 1.32; 95% CI 1.13 to 1.54; p = &amp;lt; 0.001; I2 = 10%). Patients with O blood type also had no statistically significant difference in overall survival compared to type A (HR 1.04; 95% CI 0.95 to 1.14; p = 0.43; I2 = 38%) and type B (HR 1.10; 95% CI 0.84 to 1.45; p = 0.49; I2 = 65%). Conclusions: ABO blood groups do not seem to be significantly associated with overall survival and mortality in individuals with pancreatic cancer. However, some analyses revealed significant heterogeneity between the studies. Additionally, a few studies were excluded from the plot because their results were reported in a manner that could not be integrated into a meta-analysis. Further multicenter prospective studies are still needed to validate our results. Citation Format: Tulio L Correa, Marcelo Cristalli, Pedro Luiz Lage Bodour Danielian, Vanio L J Antunes, Matheus Vanzin Fernandes, Natalia Junkes Milioli, Otavio C Martins, Cynthia Florencio de Mesquita, Stefano Baraldo, Bruno Bockorny. ABO blood type and overall survival in patients with pancreatic adenocarcinoma: A systematic review and meta-analysis [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research; 2024 Sep 15-18; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2024;84(17 Suppl_2):Abstract nr A024.

Association of ABO and Rhesus blood groups with symptom emergence in scabies: a cross-sectional study.

Scabies is a contagious skin condition caused by the Sarcoptes scabiei mite. It can lead to various clinical reactions, ranging from no symptoms at all to noticeable skin lesions and severe itching within the same household. We aimed to investigate the potential role of blood groups in the emergence of disease symptoms by comparing the scabies patients with asymptomatic co-residents. This study comprised 102 patients infected with scabies from index cases and 111 asymptomatic co-residents. The index cases where symptoms first appeared were excluded. Among patients with scabies, 34 individuals (33.3%) had type A blood group, 12 (11.8%) had type B, 27 (26.5%) had type AB, and 29 (28.4%) had type O. Of these patients, 101 (99%) were Rh+, while 1 (1%) was Rh-. In asymptomatic contacts, 61 individuals (55%) had type A, 9 (8.1%) had type B, 1 (0.9%) had type AB, and 40 (36%) had type O blood group. Of these, 102 (91.9%) were Rh+, and 9 (8.1%) were Rh-. A significant difference was observed between the two groups concerning the frequency of ABO, Rh, and ABO*Rh blood groups (p < 0.05). The prevalence of B + and AB + blood groups was higher in scabies patients compared to asymptomatic contacts. The study results showed a significant association between the emergence of scabies symptoms with blood groups. Our results highlight the importance of more research into the roles of blood group antigens in normal skin epithelium and their involvement in the etiopathogenesis of scabies.

Lack of association of ABO and RhD blood groups with COVID-19 mortality: A 2-center cross-sectional study in Saudi Arabia.

Several diseases, including both noninfectious diseases and bacterial and viral diseases, are associated with the ABO and RH blood group systems. Previous studies have shown a link between blood type and the probability of coronavirus disease 2019 (COVID-19) infection. In this study, we aimed to explore the correlation between deaths caused by COVID-19 and ABO and RhD blood types in Saudi Arabia. In this cross-sectional observational study, data from COVID-19 patients were collected from 2 major hospitals treating COVID-19 in Riyadh City, Saudi Arabia, between March 2020 and November 2021. The association between ABO and RhD blood types and COVID-19 outcomes was investigated. A total of 2302 real-time polymerase chain reaction-confirmed COVID-19 patients were enrolled in this study; a chi-square test was used to determine the statistical significance of the data. Of the 2302 enrolled patients, 1008 (43.8%) had blood type O, 677 (29.41%) had blood type A, 502 (21.8%) had blood type B, and 115 (5%) had blood type AB. Of the patients, 2143 (93.1%) were RhD-positive. The O-positive blood type had the highest mortality rate among COVID-19-infected patients, whereas the AB-negative type had the lowest. However, statistical analysis revealed no significant correlation between blood type (ABO or RhD) and COVID-19-based susceptibility or mortality. In conclusion, we found no association between ABO and RhD blood types and either susceptibility to or mortality due to COVID-19 in Saudi Arabia.

Karl Landsteiner (1868-1943): A Versatile Blood Scientist.

Karl Landsteiner (1868-1943) was an Austrian-American biologist, physician, and immunologist whose groundbreaking discoveries revolutionized the fields of transfusion medicine, immunology, and virology. His most famous work was the identification of the ABO blood group system in 1901, which explained the causes of transfusion reactions and laid the foundation for safe blood transfusions. This discovery earned him the Nobel Prize in Physiology or Medicine in 1930. Landsteiner continued his research, identifying the MN and P blood group system in 1927 and the Rh blood group system in 1940, which addressed the complexities of the Hemolytic Disease of the Fetus and Newborn (HDFN). His work on the poliovirus in 1908, in collaboration with Erwin Popper, established the infectious nature of the disease and laid the groundwork for future vaccine development. Landsteiner's versatility as a scientist is evident in the breadth of his work, spanning hematology, immunology, and virology. His ability to navigate diverse fields and see connections between them allowed him to make pioneering discoveries that have had a lasting impact on medical practice, particularly in blood transfusion, organ transplantation, and immunotherapy. Landsteiner's legacy as the "Father of Transfusion Medicine" is reinforced by the standardization of blood typing procedures, which have saved millions of lives worldwide.

Glycomics of cervicovaginal fluid from women at risk of preterm birth reveals immuno-regulatory epitopes that are hallmarks of cancer and viral glycosylation

During pregnancy the immune system needs to maintain immune tolerance of the foetus while also responding to infection, which can cause premature activation of the inflammatory pathways leading to the onset of labour and preterm birth. The vaginal microbiome is an important modifier of preterm birth risk, with Lactobacillus dominance during pregnancy associated with term delivery while high microbial diversity is associated with an increased risk of preterm birth. Glycans on glycoproteins along the lower female reproductive tract are fundamental to microbiota-host interactions and the mediation of inflammatory responses. However, the specific glycan epitopes involved in these processes are not well understood. To address this, we conducted glycomic analyses of cervicovaginal fluid (CVF) from 36 pregnant women at high risk of preterm birth and 4 non-pregnant women. Our analysis of N- and O-glycans revealed a rich CVF glycome. While O-glycans were shown to be the main carriers of ABO blood group epitopes, the main features of N-glycans were the presence of abundant paucimannose and high mannose glycans, and a remarkable diversity of complex bi-, tri-, and tetra-antennary glycans decorated with fucose and sialic acid. We identified immuno-regulatory epitopes, such as Lewis antigens, and found that fucosylation was negatively correlated to pro-inflammatory factors, such as IL-1β, MMP-8, C3a and C5a, while glycans with only sialylated antennae were mainly positively correlated to those. Similarly, paucimannose glycans showed a positive correlation to pro-inflammatory factors. We revealed a high abundance of glycans which have previously been identified as hallmarks of cancer and viral glycosylation, such as Man8 and Man9 high mannose glycans. Although each pregnant woman had a unique glycomic profile, longitudinal studies showed that the main glycosylation features were consistent throughout pregnancy in women who delivered at term, whereas women who experienced extreme preterm birth exhibited sharp changes in the CVF glycome shortly before delivery. These findings shed light on the processes underlying the role of glycosylation in maintaining a healthy vaginal microbiome and associated host immune responses. In addition, these discoveries facilitate our understanding of the lower female reproductive tract which has broad implications for women’s health.

Premarital Screening Uncovers Alarming Health Risks in Iraq

Background: Premarital screening programs, implemented globally since the 1970s, aim to improve reproductive health outcomes by identifying potential genetic and infectious risks before marriage. Specific Background: In July 2013, the Thi-Qar Governorate in Iraq introduced a premarital screening program to enhance health outcomes for pregnant women and their offspring. However, regional data on the efficacy and impact of such programs remain limited. Knowledge Gap: The prevalence and distribution of blood disorders and infectious diseases among couples in this region, and their implications for public health, have not been extensively documented. Aims: This study evaluates the pathophysiological status of couples undergoing premarital screening in Nasiriyah, Iraq, focusing on the prevalence of blood disorders and infectious diseases. Results: Data from 14,190 individuals (7095 couples) collected from January to December 2023 revealed significant health concerns: 34.40% had hemoglobin levels below 12 gm/dl, and notable percentages carried thalassemia and sickle cell anemia genes. Gender-specific analysis showed that all males tested positive for HIV, while significant proportions of females tested positive for HCV and T. palladium. No significant differences were found in the ABO blood system. Novelty: This study provides comprehensive, region-specific data on premarital screening outcomes in Iraq, highlighting significant disparities in disease prevalence between sexes and compared to other regions. Implications: The findings underscore the importance of enhancing premarital screening programs and integrating educational and preventive measures. Future research should include longitudinal studies to assess the long-term impact of these screenings and explore the benefits of incorporating genetic counseling to further mitigate hereditary and infectious risks. Highlights: High prevalence of blood disorders and infections in couples. Gender differences: all males positive for HIV, significant female infections. Need for improved education and prevention measures. Keywords: Premarital Screening, Hemoglobinopathies, Infectious Diseases, Nasiriyah, Iraq

The Role of Blood Group in Cancer Risk: Correlations with Site, Age, and Body Mass Index

Background: Cancer is a complicated group of diseases in which cells grow and divide without being controlled. It is still one of the main reasons of death in the world, which presents major public health issues. Blood group links to cancer risk have been getting more and more attention over the past few years, among other things being studied. Aim of the study: This study aimed to assess the relation between ABO blood groups and the occurrence of different cancer types among the population of Kirkuk city. Patients and methods: This cross-sectional study was carried out in Kirkuk city from the period 15th October 2023 to 15th May 2024 on cancer patients of Kirkuk's Oncology and Hematology Centre. Data was collected from medical records and patient interviews to examine demographic characteristics, lifestyle factors, medical history, and potential exposures. The study included 398 patients diagnosed with cancer within a specified time frame, selected from medical records of healthcare facilities in the target area.. Blood samples were collected from each participant in the study for determination of blood group and Rh. Results: The study reveals that breast cancer is the most prevalent cancer, accounting for 45.98% of all cases. The study presents the distribution of cancer patients according to their blood groups, with O positive and A positive blood types accounting for the highest percentage at 33.67%. Other blood types such as B positive, AB positive, O negative, B negative, AB negative, and A negative are represented in smaller percentages ranging from 1.26% to 20.60%. The duration of cancer is examined in relation to blood groups, providing insights into mean durations across different ABO blood types and Rh factors. Blood type A exhibits the longest mean duration at 1.71 years, followed closely by blood type B at 1.74 years, while blood type O presents a slightly shorter mean duration at 1.52 years. In the current study, blood group A is predominantly seen in brain cancer for males (100%), with a considerable presence in digestive system cancers, split nearly evenly between males (41.94%) and females (58.06%). Blood group B appears infrequently but is represented in the digestive system and female reproductive cancers, demonstrating a minor presence compared to other groups. Skin cancer shows a potential link between blood group distribution and family history of the disease, suggesting a genetic predisposition or a significant association worth further investigation.

Frequency of ABO and Rhesus (D) blood group among blood donors and blood requisition and utilization patterns: An insight towards optimal blood usage in a tertiary care hospital.

Objective: To determine the distribution and frequency of blood groups among the blood donors and assess the blood requisition and utilization patterns in order to strategize optimal blood utilization. Study Design: Cross-sectional Descriptive study. Setting: Fauji Foundation Hospital, Rawalpindi. Period: January 2021 to January 2024. Methods: Blood bank data including blood donor name, gender, blood groups, blood requisitions, blood issuance and blood utilization was retrieved from Fauji Foundation hospital’s management information system and blood requisition and collection forms. The quality indicators of blood utilization i.e. crossmatch/transfusion ratio and transfusion probability was calculated and analyzed using SPSS 21. Results: 22483 blood donors donated blood at our blood bank facility from January 2021-january 2024. Mean age 31±10.2 years (range: 18–56 years). Majority of the blood donors were males 96.4% (n=21682) while 3.5% (n=801) were females. A total of 21733 were replacement donors while 750 were voluntary donors. The highest blood requests were from obstetrics/gynecology department while the highest blood utilization was by the medicine department. The overall cross match to transfusion ratio was 1.3. The highest cross match to transfusion ratio of 2.5 was from obstetrics/gynecology department while the lowest was from pediatrics and oncology departments. Conclusion: The blood group O positive was the commonest blood group. Although, blood transfusion quality indicators show effective utilization however the pattern varies among different departments. Evidence-based blood utilization strategies need to be implemented for optimal utilization of blood.

Association Between ABO Blood Group, Dental Caries, Gingivitis, Impacted Teeth and Malocclusion Among Saudi Adults: A Cross-Sectional Study.

Whether there is a relationship between blood group and the likelihood of acquiring oral diseases. Therefore, the present study investigated the potential association between ABO blood groups and various dental conditions, including dental caries, gingivitis, malocclusion, and impacted teeth, in Saudi adults aged 18 years and older. A cross-sectional study was conducted on 300 participants who met the inclusion criteria. Data collection included assessment of dental caries status using the decayed missing filled teeth (DMFT) and decayed missing filled surfaces (DMFS) indices, evaluation of gingivitis using the Gingival Index, classification of malocclusion according to Angle's classification system, and recording the presence or absence of impacted teeth. The AB blood group had the significantly highest mean DMFS score (8.58±6.63), while the O blood group had the lowest mean DMFS score (6.37±4.43). Additionally, blood group O showed a slightly higher prevalence of gingivitis (51.92%) than the other blood groups. Blood group A demonstrated a higher prevalence of both Class II (34.2%) and Class III (19%) malocclusions, with statistically significant differences. Regarding impacted teeth, blood group AB (48.8%) had the highest occurrence. There exists an association between oral disease and ABO blood group in Saudi adults. The results of this study indicate that individuals with specific blood types may be more prone to oral diseases, which can aid in the early diagnosis and prevention of these conditions.

The relation between ABO blood groups and clinicopathologic characteristics of the patients with gastric adenocarcinomas

Objective: This study aimed to examine the association between blood groups and clinicopathological factors that could affect the prognosis of patients with gastric cancer. Material and Methods: In this retrospective single-center study, patients with gastric adenocarcinoma were obtained from a prospectively maintained database. The association between blood groups and clinicopathologic characteristics including sex, age, tumor location, tumor size, tumor stage, metastatic lymph node ratio (MLR), lymphovascular invasion, and perineural invasion were analyzed. Results: The study included 91 female and 221 male patients. The blood group distribution was A&gt;O&gt;B&gt;AB both in the patients and healthy donors. Non-O blood types were more common in cancer patients than in healthy donors (p= 0.038). However, there was no significant association between sex, age, tumor location, tumor stage, lymph node status, lymphovascular invasion, and perineural involvement and blood groups. ≥7 lymph node involvement and MLR of &gt;0.6 were significantly more common in patients with blood group A than in those with non-A blood groups (p= 0.034 and p= 0.018; respectively). Conclusion: The findings of this study suggest that blood group A patients are associated with higher MLR and N3 involvement, so it is possible that these patients with gastric cancer have a poorer prognosis.

Evaluation of the Blood Feeding Preference of Aedes aegypti (Diptera: Culicidae) when Offered Diabetic and Non-Diabetic Blood.

Aedes aegypti (L.,1762) is a primary vector of arboviral infections like dengue, yellow fever, Zika. Female mosquitoes are influenced by various physical and chemical cues from host when blood feeding, e.g., they find some individuals with certain blood types or certain conditions more attractive than others. This study determined whether Ae. aegypti shows a preference when offered blood from a patient with diabetes mellitus (DM), an endocrine disorder associated with abnormal glucose metabolism, compared to healthy blood from non-DMs. In the dual feeding experiments, forty newly emerged female mosquitoes were provided with two blood feeding systems with blood from a non-diabetic (healthy) and diabetic patient using artificial feeders. Blood from 12 diabetic and 12 non-diabetic patients was matched by ABO blood type (e.g., diabetic type O blood was compared with non-diabetic type O blood). The number of mosquitoes that landed and fed from each membrane was counted every 2min for thirty minutes. Ae. aegypti species significantly preferred for blood from non-diabetic individuals (50-65% among the different blood type groups) compared to blood from diabetic individuals. Using multiplex allele-specific PCR it was also determined that, Ae. aegypti significantly preferred the O blood group regardless of blood sugar level compared to others. Ae. aegypti has less preference for diabetic blood to non-diabetics. Regardless people affected with this condition need to take preventive measures to reduce mosquito bites as they tend to have weaker immune systems and can experience more severe cases of dengue.